检索结果-南通市图书馆

Pancreatic function,quality of life and costs at long-term follow-up after acute pancreatitis

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

World Journal of Gastroenterology 2010年第39期16卷 4944-4951页

作者： Bodil andersson Marie-Louise Pendse roland andersson Department of Surgery Clinical Siences LundLund University Lund University Hospital

AIM:To evaluate long-term endocrine and exocrine pancreatic function,quality of life and health care costs after mild acute pancreatitis and severe acute pancreatitis(SAP).METHODS:Patients prospectively included in 2001-2005 were followed-up after 42(36-53)*** function was evaluated with laboratory tests,the oral glucose tolerance test(OGTT),fecal elastase-1 and a *** Form(SF)-36,was ***:Fourteen patients with a history of SAP and 26 with mild acute pancreatitis were *** glucose after OGTT was higher after SAP(9.2 mmol/L vs 7.0 mmol/L,P=0.044).Diabetes mellitus or impaired glucose tolerance in fasting plasma glucose and/or 120 min plasma glucose were more common in SAP patients(11/14 vs 11/25,P=0.037).Sick leave,time until the patients could take up recreational activities and time until they had recovered were all longer after SAP(P <0.001).No significant differences in SF-36 were seen between the groups,or when comparing with age and gender matched reference *** hospital costs,including primary care,follow-up and treatment of complications,were higher after SAP(median€16572 vs €5000,P<0.001).CONCLUSION:Endocrine pancreatic function was affected,especially after severe *** requires greater resource use with long recovery,but most patients regained a good quality of life.

关键词： Acute pancreatitis Endocrine function Exocrine function Quality of life Cost

Radiofrequency ablation or percutaneous ethanol injection for the treatment of liver tumors

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

World Journal of Gastroenterology 2012年第10期18卷 1003-1008页

作者： Daniel Ansari roland andersson Department of Surgery Clinical Sciences Lund Skane University Hospital and Lund University

The liver is a common location of both primary and secondary malignancies. For unresectable liver cancer, many local ablative therapies have been developed. These include e.g., percutaneous ethanol injection (PEI), percutaneous acetic acid injection, radiofrequency ablation (RFA), cryoablation, microwave ablation, laserinduced thermotherapy, and high-intensity focused ultrasound. RFA has recently gained interest and is the most widely applied thermoablative technique. RFA allows more effective tumor control in fewer treatment sessions compared with PEI, but with a higher rate of complications. However, there are certain circumstances where PEI therapy represents a better strategy to control liver tumors than RFA, especially in situations where RFA is difficult, for example when large vessels surround the tumor. In the context of hepatocellular carcinoma (HCC), both RFA and PEI are feasible and of benefit in non-operable patients. RFA seems superior to PEI in HCC > 2 cm, and the combination of interventions may be of benefit in selected patients. Liver resection is superior to RFA for patients with HCC meeting the Milan criteria, but RFA can be employed in tumors ≤ 3 cm and where there is an increased expected operative mortality. In addition, some lines of evidence indicate that RFA and PEI can be employed as a bridge to liver transplantation. The use of RFA in colorectal liver metastases is currently limited to unresectable disease and for patients unfit for surgery. The aim of this article is to summarize the current status of RFA in the management of liver tumors and compare it to the cheap and readily available technique of PEI.

关键词： Colorectal liver metastases Hepatocellular cancer Liver resection Percutaneous ethanol injection Radiofrequency ablation

Intervention on toll-like receptors in pancreatic cancer

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

World Journal of Gastroenterology 2014年第19期20卷 5808-5817页

作者： Juan Vaz roland andersson Department of Surgery Clinical Sciences LundSkne University Hospital LundLund UniversitySE-221 85 LundSweden

Pancreatic ductal adenocarcinoma(PDA)is a devastating disease with pronounced morbidity and a high mortality *** available treatments lack convincing cost-efficiency determinations and are in most cases not associated with relevant success *** stimulation of the immune system in murine PDA models has revealed some promising *** receptors(TLRs)are pillars of the immune system that have been linked to several forms of malignancy,including lung,breast and colon *** humans,TLRs are expressed in the pancreatic cancer tissue and in several cancer cell lines,whereas they are not expressed in the normal *** the present review,we explore the current knowledge concerning the role of different TLRs associated to *** if almost all known TLRs are expressed in the pancreatic cancer microenvironment,there are only five TLRs suggested as possible therapeutic *** data points at TLR2 and TLR9 as effective tumor markers and agonists could potentially be used as *** adjuvant *** elucidation of the role of TLR3 in PDA is only in its initial *** inhibition/blockage of TLR4-related pathways has shown some promising effects,but there are still many steps left before TLR4 inhibitors can be considered as possible therapeutic ***,TLR7 antagonists seem to be potential candidates for *** of their potential in immunotherapies,all existing data indicate that TLRs are strongly involved in the pathophysiology and development of PDA.

关键词： Pancreatic cancer Pathophysiological mechanism Toll-like receptor Intervention Adjuvant therapy

Tissue factor in predicted severe acute pancreatitis

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

World Journal of Gastroenterology 2010年第48期16卷 6128-6134页

作者： Ellen andersson Jakob Axelsson Gunilla Eckerwall Daniel Ansari roland andersson Department of Surgery Clinical Sciences LundLund University Lund University Hospital

AIM: To study tissue factor (TF) in acute pancreatitis and evaluate the role of TF as a predictive marker of severity. METHODS: Forty-nine consecutive patients admitted to Lund University Hospital, fulfilling the criteria of predicted severe acute pancreatitis (AP), were recruited prospectively between 2002 and 2004. Blood samples for TF analyses were drawn at inclusion in the study and 12 h, 1 d and 3 d later. RESULTS: Twenty-seven patients developed mild AP, and 22 patients severe AP. At inclusion in the study, the groups were comparable with respect to gender, aetiology, Acute Physiology and Chronic Health Evaluation Ⅱ score, and duration of pain. At inclusion in the study and at 12 h, TF was higher in the severe AP group (P = 0.035 and P = 0.049, respectively). After 1 and 3 d, no differences in TF levels were noted. Interleukin (IL)-6 was significantly higher in the severe AP group at all of the studied time points. C-reactive protein (CRP) was significantly higher in the AP group at 1 and 3 d. In receiver operating characteristic-curves, the area under the curve (AUC) for TF was 0.679 (P = 0.035) at inclusion in the study, and a cut off level for TF of 40 pg/mL showed a sensitivity of 71% and a specificity of 67%, whereas corresponding AUC for IL-6 was 0.775, P = 0.001, and for CRP was 0.653. IL-6 showed better AUC-values than TF at all time points studied. CONCLUSION: TF-levels are raised early in severe AP. TF as an early predictive marker of severe AP is superior to CRP, but inferior to IL-6.

关键词： Acute pancreatitis Coagulation Prediction of severity Tissue factor

hENT1 expression is predictive of gemcitabine outcome in pancreatic cancer: A systematic review

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

World Journal of Gastroenterology 2014年第26期20卷 8482-8490页

作者： Stina Nordh Daniel Ansari roland andersson Department of Surgery Clinical Sciences LundLund University and Sk?ne University Hospital

High human equilibrative nucleoside transporter 1(hENT1)-expression has shown a survival benefit in pancreatic cancer patients treated with gemcitabine in several *** aim of this systematic review was to summarize the results and try to assess the predictive value of hENT1 for determining gemcitabine outcome in pancreatic *** articles were obtained from PubMed,Embase and Cochrane *** evaluating hENT1-expression in pancreatic tumor cells from patients treated with gemcitabine were *** measures were overall survival,disease-free survival(DFS),toxicity and response *** database searches identified 10 studies that met the eligibility criteria,and a total of 855 patients were *** of 10 studies showed a statistically significant longer overall survival in univariate analyses in patients with high hENT1-expression compared to those with low *** the 7 studies that reported DFS as an outcome measure,6 had statistically longer DFS in the high hENT1 *** toxicity and response rate were reported in only 2 articles and it was therefore hard to draw any major *** review provides evidence that hENT1 is a predictive marker for pancreatic cancer patients treated with *** limitations of the review have to be taken into consideration,the majority of the included studies had a retrospective design,and there was no standardized scoring protocol for hENT1-expression.

关键词： Pancreatic cancer Gemcitabine hENT1 Predictive Survival

Pancreatic cancer screening in high-risk individuals with genetic susceptibility

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

Hepatobiliary Surgery and Nutrition 2023年第4期12卷 590-592页

作者： roland andersson Daniel Ansari Department of Surgery Clinical Sciences LundLund University and Skåne University HospitalLundSweden

Pancreatic cancer is still associated with a dismal prognosis,sometimes with a 5-year survival reported up to 10%,but the true figure is probably about 5%(1).Major breakthroughs in outcomes are *** avenue for improving is survival is by earlier tumor detection,thereby increasing the proportion of patients that can undergo curative-intent surgery and concomitant *** recent years,optimistic outcomes have been reported for localized-stage disease,with 5-year survival rates of up to 44%(2).

关键词： Screening pancreatic cancer genetic

Does gemcitabine-based combination therapy improve the prognosis of unresectable pancreatic cancer?

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

World Journal of Gastroenterology 2012年第35期18卷 4944-4958页

作者： Chen Sun Daniel Ansari roland andersson De-Quan Wu Department of Surgery Second Af-filiated Hospital of Harbin Medical University Harbin 150086Heilongjiang Province China Department ofSurgery Clinical Sciences Lund Lund University Sk~ne Univer-sity Hospital SE-22185 Lurid Sweden

AIM:To assess whether gemcitabine-based combination therapy improves the prognosis of unresectable pancreatic cancer compared with gemcitabine treatment ***:A quantitative up-to-date meta-analysis was undertaken to investigate the efficacy of gemcitabine-based combination treatment compared with gemcitabine monotherapy in locally advanced or metastatic pancreatic *** was limited to highquality randomized clinical ***:Twenty-six studies were included in the present analysis,with a total of 8808 patients *** studies were divided into four subgroups based on the different kinds of cytotoxic agents,including platinum,fluoropyrimidine,camptothecin and targeted *** treated with gemcitabine monotherapy had significantly lower objective response rate [risk ratio(RR),0.72;95% confidence interval(CI):0.63-0.83;P < 0.001],and lower 1-year overall survival(RR,0.90;95%CI:0.82-0.99;P = 0.04).Gemcitabine monotherapy caused fewer complications,including fewer grade 3-4 toxicities:including vomiting(RR,0.75;95%CI:0.62-0.89;P = 0.001),diarrhea(RR,0.66;95%CI:0.49-0.89;P = 0.006),neutropenia(RR,0.88;95%CI:0.72-1.06;P = 0.18),anemia(RR,0.96;95%CI:0.82-1.12;P = 0.60),and thrombocytopenia(RR,0.76;95%CI:0.60-0.97;P = 0.03) compared with gemcitabine combination ***:Gemcitabine combination therapy provides a modest improvement of survival,but is associated with more toxicity compared with gemcitabine monotherapy.

关键词： Pancreatic cancer Gemcitabine Combina-tion therapy Outcome Meta-analysis

Proteome-based biomarkers in pancreatic cancer

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

World Journal of Gastroenterology 2011年第44期17卷 4845-4852页

作者： Chen Sun Ann H Rosendahl roland andersson Daniel Ansari Department of Surgery Clinical Sciences Lund Skane University Hospital and Lurid University SE-221 85 Lund Sweden Chen Sun Harbin Medical University Harbin 150081 Heilongjiang Province China Harbin Medical University Harbin 150081 Heilongjiang Province China

Pancreatic cancer,as a highly malignant cancer and the fourth cause of cancer-related death in world,is characterized by dismal prognosis,due to rapid disease progression,highly invasive tumour phenotype,and resistance to *** significant advances in treatment of the disease during the past decade,the survival rate is little improved.A contributory factor to the poor outcome is the lack of appropriate sensitive and specific biomarkers for early ***,biomarkers for targeting,directing and assessing therapeutic intervention,as well as for detection of residual or recurrent cancer are also ***,the identification of adequate biomarkers in pancreatic cancer is of extreme ***,accompanying the development of proteomic technology and devices,more and more potential biomarkers have appeared and are being *** this review,we provide an overview of the role of proteome-based biomarkers in pancreatic cancer,including tissue,serum,juice,urine and cell *** also discuss the possible mechanism and prospects in the *** information hopefully might be helpful for further research in the field.

关键词： Biomarkers Mass spectrometry Pancreatic cancer Proteome Screening

Primary lymph node ratio and hepatic resection for colorectal metastases

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

Hepatobiliary Surgery and Nutrition 2018年第2期7卷 149-150页

作者： Daniel Ansari William Torén roland andersson Department of Surgery Clinical Sciences LundLund University and Skane University HospitalLundSweden

Colorectal cancer(CRC)is a leading cause of death worldwide(1).The liver is the most common site for distant metastases,and approximately 50%of patients diagnosed with CRC develop hepatic metastases during the course of their disease(2).Improvements in surgical techniques,anesthesia and multimodal treatment regimens(e.g.,neoadjuvant chemotherapy and portal vein embolization)have expanded the indications for liver resection(3).Hepatic resection is nowadays offered to patients previously deemed unresectable,such as those with multiple or bilobar metastases,extrahepatic disease and recurrent *** 5-year overall survival rate after resection for CRC liver metastases is close to 60%at specialty units,with low perioperative morbidity and mortality(4,5).

关键词： metastases resection hepatic